CD8A and sarcoma: Among the eight immune populations (T cells, CD8+ T cells, cytotoxic lymphocytes, natural killer cells, B cell lineage, monocytic lineage, myeloid dendritic cells and neutrophils) and two stromal populations (endothelial cells and fibroblasts) used by MCP-counter to categorize sarcomas immune classes (SIC), DDLPS has a higher signature score than LMS in both the non-immune cell populations (p = 0.002 for fibroblasts and p = 0.047 for endothelial cells).